Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Jul 3;6(7):735–744. doi: 10.1016/j.bpsc.2020.06.015

Table 1.

Demographics and clinical characteristics

Ketamine (n= 44) HC (n=50) HC with repeat (n=17)b
Gender (F/M) 18/26 27/23 9/8
Age (years) 38.2±10.9 32.3±11.9 28.2±6.9
Education 10.1 ±2.4 10.8±1.9 11.5±1.5
Lifetime Illness (years) 20.2±12.1 --
Current episode (years)
5.3±6.6 --
Responsea 23/39 (59%) --
a

Response was defined as ≥50% improvement in Hamilton Depression Rating Scales (HDRS) 24–72 hours after the fourth ketamine infusion (T3).

b

HC with repeat (n=17) are a subset of the total cohort of HC (n=50)